CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Zhejiang Conba Pharmaceutical Co., Ltd. Company Snapshot
Business Description:
Zhejiang Conba Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. Zhejiang CONBA Pharmaceutical Co., Ltd. is engaged in the research, production and sale of traditional Chinese medicines, herbal medicines, chemical drugs, bulk drugs and healthcare products. The Company's major products are Qianliekang branded tablets and capsules for the treatment of prostatitis, Tianbaoning branded tablets and capsules for the treatment of cardiovascular and cerebrovascular disease, and CONBA branded tablets for the treatment of enteritis, among others. The Company distributes its products mainly in domestic markets, with eastern China as its major market. As of December 31, 2010, the Company had 10 major subsidiaries. On June 12, 2010, the Company completed the disposal of 80% of the equity of Yunnan Xishuangbanna Conba Herba Dendrodii Officinalis Co., Ltd. In our complete report available for purchase the company is compared to: Kunming Pharmaceutical Group Ltd., Lijun International Pharmaceutical Holding Co Ltd and Hubei Qianjiang Pharmaceutical, Ltd..
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhejiang Conba Pharmaceutical Co., Ltd.
  Stock Performance Chart for Zhejiang Conba Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 7.99
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 15.1%  
4 Weeks -25.8%   52 Weeks -9.7%  
 
Zhejiang Conba Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600572 Country: CHINA
  Exchanges: SHG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 1,799,426,000
(Year Ending Jan 2011).		 Employees: 4,519
  Currency: Chinese Renmimbi Market Cap: 5,621,764,000
  Fiscal Yr Ends: December Shares Outstanding: 703,600,000
  Share Type: A Gu Closely Held Shares: N/A
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.